Literature DB >> 16170136

Compliance: clear communication's critical.

A J Buller, B Connell, A F Spencer.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16170136      PMCID： PMC1772869          DOI： 10.1136/bjo.2005.066175

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  3 in total

1.  Persistency and tolerability of ocular hypotensive agents: population-based evidence in the management of glaucoma.

Authors:  Gail F Schwartz
Journal:  Am J Ophthalmol       Date:  2004-01       Impact factor: 5.258

2.  Compliance with treatment of patients with chronic open-angle glaucoma.

Authors:  J M MacKean; A R Elkington
Journal:  Br J Ophthalmol       Date:  1983-01       Impact factor: 4.638

3.  Patient persistency with topical ocular hypotensive therapy in a managed care population.

Authors:  Gregory Reardon; Gail F Schwartz; Essy Mozaffari
Journal:  Am J Ophthalmol       Date:  2004-01       Impact factor: 5.258
  3 in total
  6 in total

1.  Microprocessor controlled compliance monitor for eye drop medication.

Authors:  M M Hermann; M Diestelhorst
Journal:  Br J Ophthalmol       Date:  2006-03-15       Impact factor: 4.638

2.  Electronic compliance monitoring of topical treatment after ophthalmic surgery.

Authors:  Manuel Marcel Hermann; Can Ustündag; Michael Diestelhorst
Journal:  Int Ophthalmol       Date:  2010-04-07       Impact factor: 2.031

3.  Ophthalmologist-patient communication, self-efficacy, and glaucoma medication adherence.

Authors:  Betsy Sleath; Susan J Blalock; Delesha M Carpenter; Robyn Sayner; Kelly W Muir; Catherine Slota; Scott D Lawrence; Annette L Giangiacomo; Mary Elizabeth Hartnett; Gail Tudor; Jason A Goldsmith; Alan L Robin
Journal:  Ophthalmology       Date:  2014-12-24       Impact factor: 12.079

4.  The medication adherence among glaucoma patients during the coronavirus disease 2019 pandemic in Croatia.

Authors:  Dina Lešin Gaćina; Sonja Jandroković; Sania Vidas Pauk; Ivan Škegro; Jelena Bošković; Martina Tomić; Ana Pupić-Bakrač; Domagoj Vlašić
Journal:  Eur J Ophthalmol       Date:  2022-07-05       Impact factor: 1.922

5.  Patient-Physician Communication on Medication Cost during Glaucoma Visits.

Authors:  Catherine Slota; Scott A Davis; Susan J Blalock; Delesha M Carpenter; Kelly W Muir; Alan L Robin; Betsy Sleath
Journal:  Optom Vis Sci       Date:  2017-12       Impact factor: 1.973

Review 6.  Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus.

Authors:  Quang H Nguyen
Journal:  Patient Prefer Adherence       Date:  2014-06-12       Impact factor: 2.711
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.